PubMed

TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.

Daigeler A, Brenzel C, Bulut D, Geisler A, Hilgert C, Lehnhardt M, Steinau HU, Flier A, Steinstraesser L, Klein-Hitpass L, Mittelkötter U, Uhl W, Chromik AM.

J Exp Clin Cancer Res. 2008 Dec 12;27:82.PMID: 19077262 [PubMed - indexed for MEDLINE]Related articlesFree article

Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus.

Daigeler A, Chromik AM, Geisler A, Bulut D, Hilgert C, Krieg A, Klein-Hitpass L, Lehnhardt M, Uhl W, Mittelkötter U.

Int J Oncol. 2008 Jun;32(6):1205-20.PMID: 18497982 [PubMed - indexed for MEDLINE]Related articles

Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells.

Chromik AM, Daigeler A, Hilgert C, Bulut D, Geisler A, Liu V, Otte JM, Uhl W, Mittelkötter U.

J Invest Surg. 2007 Nov-Dec;20(6):339-48.PMID: 18097875 [PubMed - indexed for MEDLINE]Related articles

Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.

Itashiki Y, Harada K, Ferdous T, Yoshida H.

Anticancer Res. 2007 Jul-Aug;27(4B):2365-75.PMID: 17695527 [PubMed - indexed for MEDLINE]Related articles

Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways.

Lehnhardt M, Klein-Hitpass L, Kuhnen C, Homann HH, Daigeler A, Steinau HU, Roehrs S, Schnoor L, Steinstraesser L, Mueller O.

BMC Cancer. 2005 Jul 7;5:74.PMID: 16001973 [PubMed - indexed for MEDLINE]Related articlesFree article

Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors.

Kamat AM, Tharakan ST, Sung B, Aggarwal BB.

Cancer Res. 2009 Dec 1;69(23):8958-66. Epub 2009 Nov 10.PMID: 19903839 [PubMed - indexed for MEDLINE]Related articles

Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells.

Murtaza I, Saleem M, Adhami VM, Hafeez BB, Mukhtar H.

Cancer Res. 2009 Feb 1;69(3):1156-65. Epub 2009 Jan 27.PMID: 19176377 [PubMed - indexed for MEDLINE]Related articlesFree article

PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation.

Tanaka H, Hoshikawa Y, Oh-hara T, Koike S, Naito M, Noda T, Arai H, Tsuruo T, Fujita N.

Mol Cancer Res. 2009 Apr;7(4):557-69.PMID: 19372584 [PubMed - indexed for MEDLINE]Related articles

Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents.

Moxley KM, Chengedza S, Mangiaracina D.

Gynecol Oncol. 2009 Dec;115(3):438-42. Epub 2009 Oct 4.PMID: 19804900 [PubMed - indexed for MEDLINE]Related articles

R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.

Festa M, Petrella A, Alfano S, Parente L.

Int J Cancer. 2009 Jun 1;124(11):2728-36.PMID: 19230027 [PubMed - indexed for MEDLINE]Related articles

Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.

Darnowski JW, Goulette FA, Cousens LP, Chatterjee D, Calabresi P.

Cancer Chemother Pharmacol. 2004 Sep;54(3):249-58. Epub 2004 Jun 2.PMID: 15173956 [PubMed - indexed for MEDLINE]Related articles

Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.

Rodak R, Kubota H, Ishihara H, Eugster HP, Könü D, Möhler H, Yonekawa Y, Frei K.

J Neurosurg. 2005 Jun;102(6):1055-68.PMID: 16028765 [PubMed - indexed for MEDLINE]Related articles

Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.

Ivanov VN, Zhou H, Partridge MA, Hei TK.

Cancer Res. 2009 Apr 15;69(8):3510-9. Epub 2009 Apr 7.PMID: 19351839 [PubMed - indexed for MEDLINE]Related articles

Cytotoxic effects of camptothecin and cisplatin combined with tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in a model of primary culture of non-small cell lung cancer.

Frese S, Schüller A, Frese-Schaper M, Gugger M, Schmid RA.

Anticancer Res. 2009 Aug;29(8):2905-11.PMID: 19661294 [PubMed - indexed for MEDLINE]Related articles

Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.

Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Bhanot U, Hasel C, Möller P, Gschwend JE, Simmet T, Debatin KM, Fulda S.

Cancer Res. 2009 Mar 15;69(6):2425-34. Epub 2009 Mar 3.PMID: 19258513 [PubMed - indexed for MEDLINE]Related articles

KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway.

Siegelin MD, Siegelin Y, Habel A, Rami A, Gaiser T.

Neurobiol Dis. 2009 May;34(2):259-66.PMID: 19385057 [PubMed - indexed for MEDLINE]Related articles

Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.

Woods DC, Alvarez C, Johnson AL.

Gynecol Oncol. 2008 Mar;108(3):632-40. Epub 2008 Jan 14.PMID: 18191995 [PubMed - indexed for MEDLINE]Related articles

Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.

Aguilera DG, Das CM, Sinnappah-Kang ND, Joyce C, Taylor PH, Wen S, Hasselblatt M, Paulus W, Fuller G, Wolff JE, Gopalakrishnan V.

J Neurooncol. 2009 Jul;93(3):303-18. Epub 2009 Jan 16.PMID: 19148581 [PubMed - indexed for MEDLINE]Related articles

Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2.

Siegelin MD, Gaiser T, Habel A, Siegelin Y.

Neurosci Lett. 2009 May 1;454(3):223-8. Epub 2009 Mar 14.PMID: 19429088 [PubMed - indexed for MEDLINE]Related articles

Taurolidine--a new drug with anti-tumor and anti-angiogenic effects.

Jacobi CA, Menenakos C, Braumann C.

Anticancer Drugs. 2005 Oct;16(9):917-21. Review.PMID: 16162968 [PubMed - indexed for MEDLINE]Related articles